A Pfizer Inc. plant in China that was being inspected by Food and Drug Administration regulators in order to ship drugs to the U.S. kept a second set of quality and manufacturing records that didn’t match official ones, according to an FDA review of the facility

http://ift.tt/1P20j8V

Submitted October 31, 2015 at 09:19AM by DoremusJessup http://ift.tt/1PaYuoF